Pharma

Your Article Summary

See Latest Articles

Approval of Partial Change of API Manufacturing Method and Pharmaceutical Formulation of the Recombinant Human Erythropoietin "Epogin Injection"
Chugai Pharmaceutical Co., 05/22/09

Chugai Pharmaceutical Co., Ltd. announced that the company has acquired the approval for the partial change of the API manufacturing method and the pharmaceutical formulation of a recombinant human erythropoietin from the Japanese Ministry of Health, Labour and Welfare on April.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

Telmisartan/amlodipine: approved for high blood pressure
Formulary , 12/16/09

Eslicarbazepine: A novel antiepileptic agent designed for improved efficacy and safety
Formulary , 12/16/09

Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/16/09

 See all of Drug/Product Approvals